Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendell D Jones

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 18, 2006
DNA methylation-dependent silencing of CST6 in human breast cancer cell linesAshley G Rivenbark, Wendell D Jones, William B Coleman
BMC Genomics|April 10, 2009
Learning from microarray interlaboratory studies: measures of precision for gene expressionDavid L Duewer, Wendell D Jones, Laura H Reid, et al.
Epigenetics|November 14, 2007
DNA methylation-dependent epigenetic regulation of gene expression in MCF-7 breast cancer cellsAshley G Rivenbark, Wendell D Jones, J Devon Risher, et al.
Molecular Cancer|January 29, 2008
DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell linesJ Devon Roll, Ashley G Rivenbark, Wendell D Jones, et al.
Cancers|March 12, 2020
RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female CancersWendell D Jones, Chad M Michener, Charles Biscotti, et al.
Journal of Biomolecular Techniques : JBT|June 9, 2009
Comparison of comparative genomic hybridization technologies across microarray platformsSusan D Hester, Laura Reid, Norma Nowak, et al.
Leukemia & Lymphoma|October 16, 2020
Dexrazoxane enhances efficacy of all-<i>trans</i> retinoic acid in acute myeloid leukemia patient blast cells and cell linesEric J Norris, Yogin C Patel, Kaitlin E Klotz, et al.
Experimental and Molecular Pathology|September 19, 2013
Dysregulation of the epigenome in triple-negative breast cancers: basal-like and claudin-low breast cancers express aberrant DNA hypermethylationJ Devon Roll, Ashley G Rivenbark, Rupninder Sandhu, et al.
The Journal of Pathology|March 19, 2019
Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinomaEric J Norris, Qing Zhang, Wendell D Jones, et al.
Nature Biotechnology|December 9, 2017
The international MAQC Society launches to enhance reproducibility of high-throughput technologiesLeming Shi, Rebecca Kusko, Russell D Wolfinger, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 18, 2006
DNA methylation-dependent silencing of CST6 in human breast cancer cell linesAshley G Rivenbark, Wendell D Jones, William B Coleman
BMC Genomics|April 10, 2009
Learning from microarray interlaboratory studies: measures of precision for gene expressionDavid L Duewer, Wendell D Jones, Laura H Reid, et al.
Epigenetics|November 14, 2007
DNA methylation-dependent epigenetic regulation of gene expression in MCF-7 breast cancer cellsAshley G Rivenbark, Wendell D Jones, J Devon Risher, et al.
Molecular Cancer|January 29, 2008
DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell linesJ Devon Roll, Ashley G Rivenbark, Wendell D Jones, et al.
Cancers|March 12, 2020
RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female CancersWendell D Jones, Chad M Michener, Charles Biscotti, et al.
Journal of Biomolecular Techniques : JBT|June 9, 2009
Comparison of comparative genomic hybridization technologies across microarray platformsSusan D Hester, Laura Reid, Norma Nowak, et al.
Leukemia & Lymphoma|October 16, 2020
Dexrazoxane enhances efficacy of all-<i>trans</i> retinoic acid in acute myeloid leukemia patient blast cells and cell linesEric J Norris, Yogin C Patel, Kaitlin E Klotz, et al.
Experimental and Molecular Pathology|September 19, 2013
Dysregulation of the epigenome in triple-negative breast cancers: basal-like and claudin-low breast cancers express aberrant DNA hypermethylationJ Devon Roll, Ashley G Rivenbark, Rupninder Sandhu, et al.
The Journal of Pathology|March 19, 2019
Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinomaEric J Norris, Qing Zhang, Wendell D Jones, et al.
Nature Biotechnology|December 9, 2017
The international MAQC Society launches to enhance reproducibility of high-throughput technologiesLeming Shi, Rebecca Kusko, Russell D Wolfinger, et al.
Pageof 3